These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4378396)

  • 1. [Inhibition of neoplasms by stimulation of immunity. Experimental aspects (with review of the questions discussed)].
    Lemonde P
    Union Med Can; 1974 Oct; 103(10):1716-28. PubMed ID: 4378396
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of leukaemia.
    Malpas JS
    Schweiz Med Wochenschr; 1974 May; 104(18):626-33. PubMed ID: 4596725
    [No Abstract]   [Full Text] [Related]  

  • 4. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 5. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of drug therapy against a histologically defined rat leukemia.
    Pearson JW; Chaparas SD; Torgersen JA; Perk K; Chirigos MA; Sher NA
    Cancer Res; 1974 Feb; 34(2):355-61. PubMed ID: 4589956
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
    Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
    Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of immunotherapy, chemotherapy, and surgery on tumor immunity in mice.
    Tanaka T; Sasaki N
    Gan; 1974 Oct; 65(5):395-402. PubMed ID: 4435340
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 10. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 11. Active immunotherapy.
    Mathé G
    Adv Cancer Res; 1971; 14():1-36. PubMed ID: 4330473
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of B-16 melanoma and Lewis lung carcinoma to BCG immunoprophylaxis.
    Papilian-Todoruţiu C; Daicoviciu D
    Morphol Embryol (Bucur); 1987; 33(1):55-69. PubMed ID: 2953967
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
    Fisher B; Gebhardt M; Linta J; Saffer E
    Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of immunostimulation and chemotherapy on the growth of reticulosarcoma in mice.
    Vasarević B; Boranić M; Pavelić Z
    Biomedicine; 1974 Dec; 21(12):462-4. PubMed ID: 4618487
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy for malignant disease.
    Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

  • 17. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
    Mathé G; Hayat M; Amiel JL; Schwarzenberg L; Schneider M; Pouillart P; Cattan A
    Boll Ist Sieroter Milan; 1971; 50(4):251-9. PubMed ID: 5293498
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
    Mathe G; Amiel JL; Schwarsenberg L; Hyat M; Pouillart P; Schenider M; Cattan A; Jasmin C; Belpomme D; Schulmberger JR; De Vassal F; Musset M; Misset JL
    Folia Clin Int (Barc); 1975 Mar; 25(3):131-51. PubMed ID: 1056311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T
    Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
    Mathé G
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.